Neurocrine Biosciences (NBIX) Work In Process (2017 - 2025)

Neurocrine Biosciences (NBIX) has reported Work In Process for 9 consecutive years, with $13.8 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Work In Process rose 15.0% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2025 stood at $13.8 million (up 15.0% YoY), and the FY2024 full-year result was $10.9 million, up 12.37% from the prior year.
• Work In Process rose to $13.8 million in Q1 2025 per NBIX's latest filing, from $10.9 million in the prior quarter.
• Across five years, Work In Process topped out at $13.8 million in Q1 2025 and bottomed at $3.6 million in Q4 2021.
• Historically, Work In Process has averaged $9.8 million across 5 years, with a median of $10.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Work In Process jumped 73.21% in 2023, then increased 12.37% in 2024.
• Over 5 years, Work In Process stood at $3.6 million in 2021, then jumped by 55.56% to $5.6 million in 2022, then soared by 73.21% to $9.7 million in 2023, then climbed by 12.37% to $10.9 million in 2024, then climbed by 26.61% to $13.8 million in 2025.
• According to Business Quant data, Work In Process over the past three periods registered $13.8 million, $10.9 million, and $10.6 million for Q1 2025, Q4 2024, and Q3 2024 respectively.